Filing Details
- Accession Number:
- 0000310764-23-000121
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-21 17:18:57
- Reporting Period:
- 2023-11-17
- Accepted Time:
- 2023-11-21 17:18:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 310764 | Stryker Corp | SYK | Surgical & Medical Instruments & Apparatus (3841) | 381239739 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1519419 | Kevin Lobo | 2825 Airview Blvd Kalamazoo MI 49002 | Chair And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-17 | 160,215 | $81.14 | 241,249 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-17 | 103,732 | $291.55 | 137,517 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-11-17 | 32,857 | $287.42 | 104,660 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-11-17 | 15,092 | $288.26 | 89,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-11-17 | 8,060 | $289.12 | 81,508 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-11-17 | 474 | $289.89 | 81,034 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option granted 02/12/2014 (right to buy) | Disposition | 2023-11-17 | 160,215 | $0.00 | 160,215 | $81.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-02-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 665 | Indirect | By 401K |
Footnotes
- Includes 2,585 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of September 30, 2023, the date of the latest available statement of the reporting person's ESPP holdings.
- The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $286.77 to $287.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $287.77 to $288.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $288.77 to $289.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $289.81 to $289.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.
- Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant.
Billionaire Hedge Funds
